Inventor · disambiguated record
Ernest A. Carra
Also filed as: CARRA ERNEST · CARRA ERNEST A · CARRA ERNEST ANTHONY
20 granted patents·5 pending applications·197 citations·filing 2010–2023
95Inventor score
Files withGILEAD SCIENCES INC15GILEAD CALISTOGA LLC5SIERRA ONCOLOGY INC2CARRA ERNEST ANTHONY1GILEAD PALO ALTO INC1
Top patents by PatentIndex Score
25 records- 0197US11597742B2Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoateGILEAD SCIENCES INC·Filed 2020·Granted Mar 7, 2023·19 cites·44 claims
- 0297US10836787B2Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoateGILEAD SCIENCES INC·Filed 2018·Granted Nov 17, 2020·29 cites·12 claims
- 0396US9682084B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2015·Granted Jun 20, 2017·21 cites·20 claims
- 0495US12030906B2Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoateGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·6 cites·22 claims
- 0595US9708342B2Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olateGILEAD SCIENCES INC·Filed 2015·Granted Jul 18, 2017·20 cites·26 claims
- 0694US8865730B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2013·Granted Oct 21, 2014·25 cites·12 claims
- 0793US9469613B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2015·Granted Oct 18, 2016·15 cites·23 claims
- 0892US10098886B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·10 cites·19 claims
- 0991US10385067B2Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olateGILEAD SCIENCES INC·Filed 2017·Granted Aug 20, 2019·9 cites·19 claims
- 1089US9643956B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2015·Granted May 9, 2017·9 cites·81 claims
- 1188US9708327B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Jul 18, 2017·12 cites·47 claims
- 1288US9469643B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Oct 18, 2016·9 cites·6 claims
- 1384USRE49445EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2020·Granted Mar 7, 2023·1 cites·62 claims
- 1484US10730879B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 4, 2020·2 cites·4 claims
- 1583US9809559B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2016·Granted Nov 7, 2017·3 cites·16 claims
- 1681USRE48285EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2018·Granted Oct 27, 2020·2 cites·26 claims
- 1781US10442805B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2017·Granted Oct 15, 2019·3 cites·1 claims
- 1880USRE50497E(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGLAXOSMITHKLINE LLC·Filed 2023·Granted Jul 22, 2025·0 cites·47 claims
- 1980US10946004B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 2070US11202780B2Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2020·Granted Dec 21, 2021·0 cites·21 claims
- 2160US2019015420A1Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2253US2024174702A1Solid forms of a compound for modulating cotGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2352US2014094485A1Solid state forms of hiv inhibitorGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 2433US2011039799A1A1 adenosine receptor agonist polymorphsGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 2533US2012232038A1Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamateCARRA ERNEST ANTHONY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ernest A. Carra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →